Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Tabula Rasa HealthCare stock
Learn how to easily invest in Tabula Rasa HealthCare stock.
Tabula Rasa HealthCare Inc is a health information services business based in the US. Tabula Rasa HealthCare shares (TRHC) are listed on the NASDAQ and all prices are listed in US Dollars. Tabula Rasa HealthCare employs 1,614 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Tabula Rasa HealthCare
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – TRHC – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Tabula Rasa HealthCare stock price (NASDAQ: TRHC)Use our graph to track the performance of TRHC stocks over time.
Tabula Rasa HealthCare shares at a glance
|Latest market close||$11.18|
|52-week range||$10.05 - $69.31|
|50-day moving average||$13.50|
|200-day moving average||$31.64|
|Wall St. target price||$21.41|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-3.83|
Buy Tabula Rasa HealthCare shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Tabula Rasa HealthCare stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Tabula Rasa HealthCare price performance over time
|1 week (2022-01-21)||-20.09%|
|1 month (2021-12-28)||-21.43%|
|3 months (2021-10-28)||-58.42%|
|6 months (2021-07-28)||-74.50%|
|1 year (2021-01-28)||-79.68%|
|2 years (2020-01-28)||-79.72%|
|3 years (2019-01-28)||58.43|
|5 years (2017-01-27)||14.27|
Is Tabula Rasa HealthCare stock undervalued or overvalued?
Valuing Tabula Rasa HealthCare stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Tabula Rasa HealthCare's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Tabula Rasa HealthCare's PEG ratio
Tabula Rasa HealthCare's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 7.2944. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Tabula Rasa HealthCare's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Tabula Rasa HealthCare's EBITDA
Tabula Rasa HealthCare's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $691,000.
The EBITDA is a measure of a Tabula Rasa HealthCare's overall financial performance and is widely used to measure a its profitability.
Tabula Rasa HealthCare financials
|Revenue TTM||$322.6 million|
|Gross profit TTM||$92.4 million|
|Return on assets TTM||-8.83%|
|Return on equity TTM||-76.15%|
|Market capitalisation||$339.2 million|
TTM: trailing 12 months
Tabula Rasa HealthCare share dividends
We're not expecting Tabula Rasa HealthCare to pay a dividend over the next 12 months.
Tabula Rasa HealthCare share price volatility
Over the last 12 months, Tabula Rasa HealthCare's shares have ranged in value from as little as $10.05 up to $69.31. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Tabula Rasa HealthCare's is 1.0502. This would suggest that Tabula Rasa HealthCare's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Tabula Rasa HealthCare overview
Tabula Rasa HealthCare, Inc. operates as a healthcare technology company in the United States. The company operates through two segments, CareVention HealthCare and MedWise HealthCare. It offers EireneRx, a cloud-based medication decision-support and e-prescribing platform to access patient medication-related information; and MedWise software that provides medication decision support components for clients seeking to manage their medication risk and improve medication outcomes, and patient relationships by enhancing their existing programs or systems. The company also provides RxCompanion, a cloud-based MTM software platform designed to aid in the identification and resolution of medication and other health related problems; TruChart, a web-based electronic health record for Programs of All-Inclusive Care for the Elderly (PACE) organizations; PACElogic, which delivers real-time sharable workflows comprising EHR, customer relationship management, claims adjudication, electronic data interchange, care management, coordination and planning, integration with community-based providers, and various federal and state required reporting. In addition, the company offers DoseMeRx, a decision support software; PrescribeWellness, a patient engagement center platform; and clinical pharmacist collaboration, prescription fulfillment and reminder packaging, and pharmacy cost management services, as well as health plan management services, including risk adjustment and third party administrator services. As of December 31, 2020, it served approximately 130 healthcare organizations; and 280 health plans and approximately 14,000 retail pharmacies.
Tabula Rasa HealthCare in the news
Netflix shares fall near pre-pandemic level as investors fear slowing subscriber growth, competition
Stocks making the biggest moves midday: Netflix, Kohl's, Wynn Resorts, General Motors and more
RBC upgrades Comcast to outperform on subscriber growth
Frequently asked questionsWhat percentage of Tabula Rasa HealthCare is owned by insiders or institutions?
Currently 5.733% of Tabula Rasa HealthCare shares are held by insiders and 101.187% by institutions. How many people work for Tabula Rasa HealthCare?
Latest data suggests 1,614 work at Tabula Rasa HealthCare. When does the fiscal year end for Tabula Rasa HealthCare?
Tabula Rasa HealthCare's fiscal year ends in December. Where is Tabula Rasa HealthCare based?
Tabula Rasa HealthCare's address is: 228 Strawbridge Drive, Moorestown, NJ, United States, 08057 What is Tabula Rasa HealthCare's ISIN number?
Tabula Rasa HealthCare's international securities identification number is: US8733791011 What is Tabula Rasa HealthCare's CUSIP number?
Tabula Rasa HealthCare's Committee on Uniform Securities Identification Procedures number is: 873379101
More guides on Finder
Cathie Wood’s ARK analysts predict Bitcoin at $1 million each by 2030
Five major factors contribute to the continued bull run of Bitcoin, ARK says, including growing adoption and long-term focus of investors.
Lido’s liquid staking allows investors holding LUNA and less than 32 ETH to reap the rewards of DeFi staking.
Stocks are dropping; 3 rules for buying on the dip
Downturns often let you buy fundamentally strong stocks at bargain prices, but mind the fundamentals and consider these 3 rules.
Walmart dives deep into the metaverse with crypto and NFTs
Walmart files trademarks with the goal to issue its own cryptocurrency and NFTs for use in its digital stores.
Melania Trump has an NFT — what to know before you buy
Melania Trump launched an NFT platform — you can buy an image of her eyes.
Vigorus (VIS) price prediction
Read our expert analysis on Vigorus and how the token will perform in the future.
Today’s top U.S. stocks: Mechel Pao ADRs (MTL ↑8.1%), Sibanye-Stillwater Limited (SBSW ↑7.4%)
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
How to order free at-home COVID tests today — but note, there’s a wait
Starting Jan. 18, every household can order up to four free at-home COVID-19 tests. But you’ll have to wait for them.
Today’s top U.S. stocks: Las Vegas Sands (LVS ↑15.3%), Wynn Resorts Limited (WYNN ↑9.1%)
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Donut savings review
Donut earns up to 10% APY, but you must have an iOS device.
Ask an Expert